COVID-19 vaccine 'Covaxin' to the age group of 18-44 years due to unavailability of its stock, said Aam Aadmi Party (AAP) MLA Atishi Marlena on Wednesday."Despite the number of vaccination centres being increased extensively, the stock for Covaxin is absolutely finished, and due to this, nearly 100 centres administering Covaxin have been forced to temporarily shut down.
So, from Thursday, Delhi will not be able to administer Covaxin to the 18-44 age group, due to the shortage of vaccines. Bharat Biotech has refused to deliver any additional doses of Covaxin to Delhi," Atishi said."We are hoping that the Central government intervenes in the matter and supplies sufficient Covaxin vials to Delhi.